Xedev

Executive Summary

Xedev is a flexible Contract Development and Manufacturing Organization (CDMO) based in Ghent, Belgium, specializing in transforming promising compounds into clinical formulations. The company offers formulation, process development, and manufacturing services for solid dosage forms, powders, and advanced drug delivery solutions. By providing science-driven, cost-efficient services from early-stage R&D to GMP-compliant clinical production, Xedev accelerates the path to the clinic for its clients. Founded in 2016, the company is privately held and operates in the preclinical stage, serving the medical devices and drug delivery sectors. Its strategic location in Ghent, a hub for life sciences, positions it well to collaborate with European biotechs and pharma companies. As a CDMO, Xedev's growth is tied to the outsourcing trends in pharmaceutical R&D and the increasing demand for flexible, high-quality manufacturing partners. The company's focus on customer intimacy and scientific excellence helps it differentiate in a competitive market. With a lean structure and a reputation for reliability, Xedev is poised to capture opportunities in the growing early-stage clinical manufacturing space.

Upcoming Catalysts (preview)

• Q3 2026Securing a multi-year contract with a top-20 pharma company40% success
• Q4 2026Expansion of GMP manufacturing capacity at Ghent facility70% success
• Q2 2026Strategic partnership with a drug delivery technology platform50% success